With our current study, we can further add that SCLC metastases mimicked the primary tumor regarding decreased intratumoral vessel density, T cell infiltration, and exhaustion when using a small-molecule inhibitor for VEGFR. The gene discussed is KDR; the disease is small cell lung carcinoma.